BioHarvest Sciences Inc.
BHST
$4.21
-$0.04-0.94%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.77% | 30.86% | 25.67% | 52.86% | -2.78% |
| Total Depreciation and Amortization | 29.82% | 36.06% | 51.01% | 71.56% | 48.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.60% | -59.09% | -57.48% | -92.20% | 126.11% |
| Change in Net Operating Assets | -249.91% | -66.95% | -117.07% | 86.09% | -173.51% |
| Cash from Operations | -8.11% | -1.02% | -7.75% | 22.64% | 21.57% |
| Capital Expenditure | 16.93% | 23.38% | 18.04% | -149.77% | -92.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 94.79% | 98.38% | 116.44% | -- | -- |
| Cash from Investing | 21.87% | 28.14% | 25.71% | -164.02% | -105.36% |
| Total Debt Issued | 262.95% | 93.31% | 12.24% | -47.26% | -74.72% |
| Total Debt Repaid | -431.85% | -271.31% | -270.44% | -257.80% | -277.75% |
| Issuance of Common Stock | 429.72% | 23.24% | -100.00% | 1,035.82% | 1,075.68% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 345.24% | 56.14% | -38.51% | -21.87% | -49.99% |
| Foreign Exchange rate Adjustments | 214.71% | -149.38% | -175.29% | -144.87% | -157.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 795.95% | 578.08% | -142.94% | -101.12% | -181.93% |